Area of research
Nuclear and High Energy Physics · Psychiatry and Mental health
Research interest
Research interests include Particle physics theoretical and experimental studies, Dementia and Cognitive Impairment Research, Quantum Chromodynamics and Particle Interactions, and Schizophrenia research and treatment.
Development of a diagnostic checklist to identify functional cognitive disorder versus other neurocognitive disorders
Antihypertensive drug classes and risk of incident dementia: a multinational population-based cohort study
Dementia prevention, intervention, and care: 2024 report of the Lancet standing Commission
Acceptance and Commitment Therapy plus usual care for improving quality of life in people with motor neuron disease (COMMEND): a multicentre, parallel, randomised controlled trial in the UK
Perspectives on the diagnosis and management of functional cognitive disorder: An international Delphi study
A leaky umbrella has little value: evidence clearly indicates the serotonin system is implicated in depression
Priorities for research on neuromodulatory subcortical systems in Alzheimer's disease: Position paper from the NSS PIA of ISTAART
Key questions for the evaluation of anti-amyloid immunotherapies for Alzheimer’s disease
Metacognition in functional cognitive disorder
The COVID-19 pandemic has highlighted the need to invest in care home research infrastructure
Dementia wellbeing and COVID‐19: Review and expert consensus on current research and knowledge gaps
Assistive technology and telecare to maintain independent living at home for people with dementia: the ATTILA RCT
Psychosis in systemic lupus erythematosus (SLE): 40-year experience of a specialist centre
Association between risk of dementia and very late-onset schizophrenia-like psychosis: a Swedish population-based cohort study
Understanding Alzheimer's disease as a disorder of consciousness
Dementia prevention, intervention, and care: 2020 report of the Lancet Commission
Functional cognitive disorder: dementia’s blind spot
The effectiveness and cost-effectiveness of assistive technology and telecare for independent living in dementia: a randomised controlled trial
Neuropsychiatric symptoms in limbic-predominant age-related TDP-43 encephalopathy and Alzheimer’s disease
Regular mass screening for SARS-CoV-2 infection in care homes already affected by COVID-19 outbreaks: Implications of false positive test results
Non‐memory cognitive symptom development in Alzheimer's disease
Locus coeruleus imaging as a biomarker for noradrenergic dysfunction in neurodegenerative diseases
Effect of computerised cognitive training on cognitive outcomes in mild cognitive impairment: a systematic review and meta-analysis
Minocycline at 2 Different Dosages vs Placebo for Patients With Mild Alzheimer Disease
Metacognition in functional cognitive disorder- a potential mechanism and treatment target
Trazodone use and risk of dementia: A population-based cohort study
Plastic waste associated with disease on coral reefs
Nilvadipine in mild to moderate Alzheimer disease: A randomised controlled trial
Antipsychotic treatment of very late-onset schizophrenia-like psychosis (ATLAS): a randomised, controlled, double-blind trial
Dementia prevention, intervention, and care